WAP
NBRV

Wealthcare Advisory Partners’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Wealthcare Advisory Partners’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 2111
2021
Q1 		$0 Buy
+1
New +$62 ﹤0.01% 2129
2020
Q2 		– Sell
-1
Closed – – 1515
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1623
2019
Q4 		$0 Buy
+1
New +$459 ﹤0.01% 1460

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Wealthcare Advisory Partners's NBRV Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2021, closing a stake of 1 share.

Wealthcare Advisory Partners first reported a position in NBRV in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2021. 31 funds tracked by Wall St. Rank hold NBRV as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1 Nabriva Therapeutics plc Ordinary Shares Ireland share in Q2 2021.
  • Wealthcare Advisory Partners first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2019 and held it in 3 quarters.
  • Wealthcare Advisory Partners's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $0 in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.